{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Choose the appropriate assessment techniques for patients who have Kaposi sarcoma.
  2. Identify the recommended diagnostic approaches to Kaposi sarcoma.
  3. Select the best practices for managing Kaposi sarcoma.

Learning Outcomes

Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding Kaposi sarcoma, including its epidemiology and characteristics, management of epidemic Kaposi sarcoma, and the specific nursing considerations in the care of people living with HIV who have Kaposi sarcoma by achieving a minimum score of 70% on the outcomes based posttest.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Test Code: AJN1222
Published: December 2022
Expires: 9/5/2025
Required Passing Score: 8/10 (80%)
Authors: Ralph F. Mangusan, DNP, MPH, CRNP, CWCN-AP, AAHIVS; Irene Ekwede, MSN, RN; Anaida Widell, BSN, RN, PCCN
Topics: Kaposi Sarcoma